Search - tctmd.com

Displaying 61 - 80 of 382

Sort: Relevancy | Date

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

News Daily News

Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients

April 22, 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

April 16, 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

April 11, 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presentation ACC 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presenter: David E. Kandzari

April 08, 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

April 06, 2024

Antihypertensives Linked to Lower Long-term Dementia Risk

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

April 01, 2024

Biologic Winrevair Wins FDA Approval for Treatment of PAH

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

March 27, 2024

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

Peer Coaching May Help With BP Control in Rural Black Populations

News Daily News

Peer Coaching May Help With BP Control in Rural Black Populations

March 22, 2024

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Top General Cardiology and CVD Prevention News of 2023

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

High Systolic BP, LDL at a Young Age Matter Later in Life

News Daily News

High Systolic BP, LDL at a Young Age Matter Later in Life

December 26, 2023

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

December 06, 2023

December 2023 Dispatch for the CV Team

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

December 01, 2023

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

News Daily News

Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s

Michael O'Riordan

November 29, 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

November 20, 2023

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Presentation AHA 2023

Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial

Presenter: Jamie Kitt

November 17, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.